Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: Four-year results of Austrian Breast Cancer Study Group (ABCSG) Trial 5. - Jakesz,R.; Hausmaninger,H.; Samonigg,H. (Proc Ann Meet Soc Clin Oncol., 1999)